Empagliflozin improves cardiac mitochondrial function and survival through energy regulation in a murine model of heart failure.
European Journal of Pharmacology(2022)
Abstract
Schematic figures depicting the proposed mechanisms of how empagliflozin improves heart failure by modulating the energetic cycle.Image 1
MoreTranslated text
Key words
Empagliflozin,SGLT2 inhibitor,Heart failure,Energy metabolism,Mitochondria
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined